The Associated Press reports.

These outcomes were statistically significant in comparison to placebo. The safety outcomes were in keeping with the known safety profile of HUMIRA. Incidence of injection site reaction-related adverse occasions and hematologic adverse events were higher in HUMIRA-treated patients compared to placebo-treated sufferers. People coping with ulcerative colitis currently have very few treatment options to help them manage their disease, said Eugene Sun, M.D., vice president, Global Pharmaceutical Clinical Advancement, Abbott. We are encouraged by these study outcomes with HUMIRA and the potential they may have for sufferers.Dominic ffytcheBrain health: how can you decrease cognitive decline? An interview with Heather Snyder, Ph.D.Jumping genes: a marker for early cancer tumor medical diagnosis? An interview with Dr KazazianThe RF cochlea, embedded on a silicon chip measuring 1.5 mm by 3 mm, works as an analog spectrum analyzer, detecting the composition of any electromagnetic waves within its perception vary. Electromagnetic waves travel through digital inductors and capacitors . Electronic transistors play the function of the cochlea’s hair cells. The analog RF cochlea chip is definitely faster than any additional RF spectrum analyzer and consumes about 100 occasions less power than what would be required for immediate digitization of the entire bandwidth.